A Phase I, open-label study of the absorption, metabolism, and excretion of [14C]-GDC-6036 following a single oral dose in healthy male subjects
Latest Information Update: 02 Nov 2023
At a glance
- Drugs Divarasib (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Roche
Most Recent Events
- 20 Mar 2023 New trial record
- 17 Mar 2023 Status changed from active, no longer recruiting to completed.
- 17 Mar 2023 Status changed from not yet recruiting to active, no longer recruiting.